Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0S7TM
|
||||
Former ID |
DNC014389
|
||||
Drug Name |
2,2'-bi(1,3,4-thiadiazole)-5,5'(4H,4'H)-dithione
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C4H2N4S4
|
||||
Canonical SMILES |
C1(=NNC(=S)S1)C2=NNC(=S)S2
|
||||
InChI |
1S/C4H2N4S4/c9-3-7-5-1(11-3)2-6-8-4(10)12-2/h(H,7,9)(H,8,10)
|
||||
InChIKey |
DAHNZAVSTBXUBS-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Tyrosine oxidase | Target Info | Inhibitor | [1] | |
BioCyc Pathway | (S)-reticuline biosynthesis | ||||
Eumelanin biosynthesis | |||||
L-dopachrome biosynthesis | |||||
KEGG Pathway | Tyrosine metabolism | ||||
Riboflavin metabolism | |||||
Metabolic pathways | |||||
Melanogenesis | |||||
PathWhiz Pathway | Riboflavin Metabolism | ||||
Tyrosine Metabolism | |||||
WikiPathways | Dopamine metabolism | ||||
References | |||||
REF 1 | Bioorg Med Chem. 2010 Jun 1;18(11):4042-8. Epub 2010 Apr 13.New potent inhibitors of tyrosinase: novel clues to binding of 1,3,4-thiadiazole-2(3H)-thiones, 1,3,4-oxadiazole-2(3H)-thiones, 4-amino-1,2,4-triazole-5(4H)-thiones, and substituted hydrazides to the dicopper active site. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.